Emergent BioSolutions signed five-year agreement for large-scale drug substance manufacturing for Johnson & Johnson’s COVID-19 vaccine candidate
On Jul. 6, 2020, Emergent BioSolutions announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, a Johnson &…